Ronghao Wang

Preclinical Study using Malat1 Small Interfering RNA or Androgen Receptor Splicing Variant 7 Degradation Enhancer ASC-J9 ® to Suppress Enzalutamide-resistant Prostate Cancer Progression

Ronghao Wang, Yin Sun, Lei Li et al. · European Urology · 2017 · 143 citations · Full text

Urology, Medicine, Preclinical Study +4

Estrogen receptor β promotes the vasculogenic mimicry (VM) and cell invasion via altering the lncRNA-MALAT1/miR-145-5p/NEDD9 signals in lung cancer

Weiwei Yu, Jie Ding, Maio He et al. · Oncogene · 2018 · 118 citations

Estrogen Receptor β, Medicine, Cancer Cell Biology +8

SH3BGRL2 inhibits growth and metastasis in clear cell renal cell carcinoma via activating hippo/TEAD1-Twist1 pathway

Lei Yin, Wenjia Li, Aiming Xu et al. · EBioMedicine · 2020 · 78 citations · Full text

Urology, Genitourinary Cancer, Medicine +6

Targeting androgen receptor (AR) with antiandrogen Enzalutamide increases prostate cancer cell invasion yet decreases bladder cancer cell invasion via differentially altering the AR/circRNA-ARC1/miR-125b-2-3p or miR-4736/PPARγ/MMP-9 signals

Gang Deng, Ronghao Wang, Yin Sun et al. · Cell Death and Differentiation · 2021 · 60 citations · Full text

ASC-J9® suppresses castration resistant prostate cancer progression via degrading the enzalutamide-induced androgen receptor mutant AR-F876L

Ronghao Wang, Wanying Lin, Chang-Yi Lin et al. · Cancer Letters · 2016 · 59 citations

Urology, Oncology, Genitourinary Cancer +6